Fails 4 of 8 criteria. S3, pharmacy identification: The site names no filling pharmacy. The footer, the product pages and the shipping policy say only that treatments come from licensed U.S. pharmacies. 3 more criteria also fail; see the table below.
At a glance
Nirwana HealthTelehealth service
4/8criteria passed
Price
Semaglutide $149 a month introductory (no later price printed), $99 a month on a 6-month plan
Sells
compounded semaglutide injection and oral tablet, and 11 more
Telehealth service. Passes 4 of 8 criteria. Recorded against Standard v1.1.
A telehealth service selling compounded semaglutide and tirzepatide as weekly injections or daily tablets, alongside sermorelin, tesamorelin, NAD+, GHK-Cu, glutathione and PT-141, with a price for every plan on the product pages. It names no pharmacy and prints no street address.
The evidence behind each disposition in the table above, where it appears, and its date.
S1PASSA board-certified U.S. physician reviews each intake and prescribes within 48 hours if appropriate, and the terms say a provider relationship begins only after a provider has conducted an appropriate evaluation.Source: Nirwana Health's website; Nirwana Health's terms of service page.
S2PASSThe start button opens an order summary and then a consent step to register, with no payment form on either, and the site states that a health questionnaire and a physician review come first and that payment is due only if prescribed.Source: Nirwana Health's nirwana health semaglutide injection page; Nirwana Health's website.
S3FAILThe site names no filling pharmacy. The footer, the product pages and the shipping policy say only that treatments come from licensed U.S. pharmacies.Source: Nirwana Health's website; Nirwana Health's shipping policy; Nirwana Health's terms of service page.
S4FAILThe semaglutide and tirzepatide pages call the drug a compounded GLP-1 medication and never say that a compounded drug is not FDA-approved, and the answers page says semaglutide is approved for chronic weight management. Only the NAD+ page states that FDA does not approve compounded medications.Source: Nirwana Health's semaglutide page; Nirwana Health's FAQ; Nirwana Health's anti aging page.
S5FAILNo certificate of analysis or lot document is published on the product pages, the answers page, the terms or the policies.Source: Nirwana Health's website; Nirwana Health's terms of service page.
S6FAILNo street address is printed for Nirwana Healthcare LLC. The terms, the privacy policy and the shipping and refund policies give none, the footer gives only an email address, and no contact page is linked.Source: Nirwana Health's terms of service page; Nirwana Health's privacy policy; Nirwana Health's website.
S7PASSCompounded semaglutide injection at $149 a month on a monthly subscription, which the page labels an introductory rate under a summer sale with no later price printed, $199 for a one-time month, $133 a month on a 3-month plan billed $399 and $99 a month on a 6-month plan. Compounded tirzepatide at $229 a month on a monthly subscription and $279 for a one-time month, while the pricing table on the same page lists a 1-month injection at $199 a month as an introductory rate with no later price printed and a 3-month plan at $166 a month. Sermorelin from $125 a month, tesamorelin and GHK-Cu from $116, NAD+ from $167, glutathione and MIC + B12 from $100, and PT-141 at $399 as a one-time treatment.Source: Nirwana Health's semaglutide page; Nirwana Health's tirzepatide page; Nirwana Health's tesamorelin page; Nirwana Health's PT-141 page.
S8PASSNo FDA warning letter names Nirwana Health or Nirwana Healthcare LLC, and no action has halted the business.Source: FDA warning-letter index.
Products shown on the seller's own pages at the recorded date: compounded semaglutide injection and oral tablet, compounded tirzepatide injection and oral tablet, sermorelin, tesamorelin, NAD+ injection and nasal spray, GHK-Cu injection and cream, glutathione injection, PT-141, MIC + B12, testosterone, finasteride and minoxidil, sildenafil and tadalafil.
Dispositions recorded against Standard v1.1. Method and null semantics: how checks are performed. This record is not a review and contains no medical advice.